Human ACE-2 is the main receptor and point of entry for SARS-CoV2 in the alveolar compartment of the lungs, as such motivating strategies to reduce its expression in alveolar epithelial cells in COVID-19 (30). This evidence concerns the gene ACE2 and COVID-19.